Rice Intervention in Chronic Health Study

NCT ID: NCT06560541

Last Updated: 2024-08-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

204 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-28

Study Completion Date

2024-08-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn if the low glycemic index (GI), polyphenol-rich red pigmented rice (UKMRC9) works to improve cardio-metabolic parameters in Malaysian adults with type 2 diabetes (T2D) and healthy individuals. It will also learn about the molecular and metabolic effects of UKMRC9 as well as its consumer acceptance. The main questions it aims to answer are:

1. What are the effects of substituting white rice with UKMRC9 on cardio-metabolic parameters, including adiposity indices, glycemic control, lipid profiles, appetite hormones, total antioxidant capacity, inflammatory markers, blood pressure, and 10-year cardiovascular risk in Malaysian adults T2D patients and healthy individuals?
2. What are the effects of substituting white rice with UKMRC9 on urinary and plasma metabolome in Malaysian adults T2D patients and healthy individuals?
3. What are the effects of substituting white rice with UKMRC9 on mitochondrial DNA methylation and circulating exosomal microRNAs expression in Malaysian adults T2D patients and healthy individuals?
4. What is the difference in consumer acceptance toward UKMRC9 compared to white rice?
5. What are the facilitators and barriers to the inclusion of UKMRC9 as a staple food in Malaysian diet?
6. What are the dietary quality and dietary pattern among Malaysian adults T2D patients and healthy individuals?
7. What is the effects of substituting white rice with UKMRC9 on advanced glycation end (AGE) products among Malaysian adults T2D patients and healthy individuals?

Researchers will compare UKMRC9 to white rice to see if UKMRC9 works to improve cardio-metabolic parameters in Malaysian adults T2D patients and healthy individuals.

Participants will:

* Take UKMRC9 or white rice everyday for 24 weeks.
* Visit the study sites once every 12 weeks for follow-up assessments.
* Share their experience in substituting white rice with UKMRC9 in focus group discussion at the end of the intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus, Type 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Although the participants will not be blinded to the investigator product (IP), they will be masked from the brand of the IP.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Diabetes Patients Cohort Red Rice (DPC-RR)

Group Type EXPERIMENTAL

UKMRC9

Intervention Type OTHER

UKMRC9 is a low glycemic index and polyphenol-rich red pigmented rice

Diabetes Patients Cohort White Rice (DPC-WR)

Group Type PLACEBO_COMPARATOR

White rice

Intervention Type OTHER

White rice refers to a local polished rice

Healthy Control Cohort Red Rice (HCC-RR)

Group Type EXPERIMENTAL

UKMRC9

Intervention Type OTHER

UKMRC9 is a low glycemic index and polyphenol-rich red pigmented rice

Healthy Control Cohort White Rice (HCC-WR)

Group Type PLACEBO_COMPARATOR

White rice

Intervention Type OTHER

White rice refers to a local polished rice

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

UKMRC9

UKMRC9 is a low glycemic index and polyphenol-rich red pigmented rice

Intervention Type OTHER

White rice

White rice refers to a local polished rice

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Attending outpatient clinics
* Age 18 - 60 years (i.e. adult population)
* Both male and female
* Regular consumption of polished white rice (presumably high-GI) ≥ 200g/day
* Established T2DM patients on oral medication
* Glycated hemoglobin (HbA1c) 7% to 10%
* Willing to take part and being compliant to the study protocol


* Healthy free living
* With glycated haemoglobin (HbA1c \<6.3%)
* Age 18 - 60 years (i.e. adult population)
* Both male and female
* Regular consumption of polished white rice (presumably high-GI) ≥ 200g/day
* Generally, physically and mentally healthy as per medical examination.
* Willing to take part and being compliant to the study protocol.

Exclusion Criteria

* Glycated hemoglobin (HbA1c) \<7% or \>10%
* Use of insulin
* A change in the type of treatment (e.g. insulin injection) during the intervention period
* Regular consumption of low-GI rice types (basmati) or colored rice (red rice, purple rice, black rice) for ≥3 months.
* Oral corticosteroids \> 3 months
* Pregnancy
* Unstable medical condition.
* Undergone any major operation in the past 3 months
* Chronic alcohol drinker.
* Not on weight loss diets or supplementation.
* Taking part in another clinical trial.

Healthy arm:


* Regular consumption of low-GI rice types (basmati) or colored rice (red rice, purple rice, black rice) for ≥3 months
* Presence of gastrointestinal disease, metabolic diseases such as diabetes, kidney failure, liver or pancreatic disease, hyperthyroidism, cancer or severe malnutrition.
* Oral corticosteroids \> 3 months
* Pregnancy
* Undergone any major operation in the past 3 months
* Chronic alcohol drinker.
* Not on weight loss diets or supplementation..
* Taking part in another clinical trial.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National University of Malaysia

OTHER

Sponsor Role collaborator

Universiti Putra Malaysia

OTHER

Sponsor Role collaborator

National Institutes of Health, Ministry of Health Malaysia

OTHER

Sponsor Role collaborator

University of Nottingham Malaysia

OTHER

Sponsor Role collaborator

Taylor's University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tilakavati Karupaiah

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tilakavati Karupaiah, PhD

Role: PRINCIPAL_INVESTIGATOR

Taylor's University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Canselor Tuanku Muhriz

Cheras, Kuala Lumpur, Malaysia

Site Status

Klinik Kesihatan Cheras

Cheras, Kuala Lumpur, Malaysia

Site Status

Klinik Kesihatan Bandar Baru Bangi

Bangi, Selangor, Malaysia

Site Status

Klinik Kesihatan Kajang

Kajang, Selangor, Malaysia

Site Status

Klinik Kesihatan Sungai Chua

Kajang, Selangor, Malaysia

Site Status

The University of Nottingham Malaysia Compus

Semenyih, Selangor, Malaysia

Site Status

Hospital Pengajar Universiti Putra Malaysia

Seri Kembangan, Selangor, Malaysia

Site Status

Universiti Putra Malaysia

Seri Kembangan, Selangor, Malaysia

Site Status

Institute for Medical Research

Shah Alam, Selangor, Malaysia

Site Status

Taylor's University

Subang Jaya, Selangor, Malaysia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Malaysia

References

Explore related publications, articles, or registry entries linked to this study.

Yu J, Balaji B, Tinajero M, Jarvis S, Khan T, Vasudevan S, Ranawana V, Poobalan A, Bhupathiraju S, Sun Q, Willett W, Hu FB, Jenkins DJA, Mohan V, Malik VS. White rice, brown rice and the risk of type 2 diabetes: a systematic review and meta-analysis. BMJ Open. 2022 Sep 27;12(9):e065426. doi: 10.1136/bmjopen-2022-065426.

Reference Type BACKGROUND
PMID: 36167362 (View on PubMed)

Golzarand M, Toolabi K, Eskandari Delfan S, Mirmiran P. The effect of brown rice compared to white rice on adiposity indices, lipid profile, and glycemic markers: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2022;62(27):7395-7412. doi: 10.1080/10408398.2021.1914541. Epub 2021 Apr 27.

Reference Type BACKGROUND
PMID: 33905269 (View on PubMed)

Abdul Rahim AF, Norhayati MN, Zainudin AM. The effect of a brown-rice diets on glycemic control and metabolic parameters in prediabetes and type 2 diabetes mellitus: a meta-analysis of randomized controlled trials and controlled clinical trials. PeerJ. 2021 May 26;9:e11291. doi: 10.7717/peerj.11291. eCollection 2021.

Reference Type BACKGROUND
PMID: 34123581 (View on PubMed)

Mendoza-Sarmiento D, Mistades EV, Hill AM. Effect of Pigmented Rice Consumption on Cardiometabolic Risk Factors: A Systematic Review of Randomized Controlled Trials. Curr Nutr Rep. 2023 Dec;12(4):797-812. doi: 10.1007/s13668-023-00496-7. Epub 2023 Sep 7.

Reference Type BACKGROUND
PMID: 37676476 (View on PubMed)

Malik VS, Sudha V, Wedick NM, RamyaBai M, Vijayalakshmi P, Lakshmipriya N, Gayathri R, Kokila A, Jones C, Hong B, Li R, Krishnaswamy K, Anjana RM, Spiegelman D, Willett WC, Hu FB, Mohan V. Substituting brown rice for white rice on diabetes risk factors in India: a randomised controlled trial. Br J Nutr. 2019 Jun;121(12):1389-1397. doi: 10.1017/S000711451900076X. Epub 2019 Apr 22.

Reference Type BACKGROUND
PMID: 31006420 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RD0120Q1410

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Multiple Grain in Type 2 Diabetes
NCT00337337 UNKNOWN PHASE4
Glycemic Index of Foods
NCT01205698 COMPLETED NA